CULVER CITY, Calif., April 25, 2024--ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab) and standard-of-care chemotherapy to be discussed during the upcoming conference call. The results continue to reinforce ImmunityBio’s belief in the unique mechanism of action of ANKTIVA (N-803, or
ALBANY, N.Y., April 25, 2024--Wright Electric, a world leader in electric propulsion for large commercial aircraft, today announced the launch of its Wright Electric Aircraft Engine Test Cell (WEAETC). The WEAETC is designed to characterize the performance of megawatt-class electric aircraft propulsion systems.
TAMPA, Fla., April 25, 2024--Systal Technology Solutions, a global managed network, cloud, and security transformation specialist, today announces the opening of its new Network Operations Center (NOC) in Tampa, Florida. This marks the latest milestone in Systal’s recent growth trajectory and global expansion, with the cutting-edge facility designed to support Systal’s existing US customer base and meet rising market demand for managed network, cloud and cybersecurity services across North Ameri